Turning Point Brands Insider Trims Stake by 25k Shares, Still Holds 330k
Rhea-AI Filing Summary
Turning Point Brands, Inc. (TPB) director Lawrence Wexler disclosed an insider sale in a Form 4 filed on 06/18/2025. On 06/17/2025 he sold 25,000 common shares at a weighted-average price of $75.94, generating roughly $1.9 million in gross proceeds. After the sale, Wexler retains 330,186 TPB shares (comprised of 3,352 restricted stock units and 326,834 common shares) and holds 114,719 vested and un-vested stock options with strike prices ranging from $14.85 to $51.75 that expire between 2027 and 2031. The divestiture represents about 7.6% of his directly held common stock position, leaving him with a meaningful ownership stake. No purchases were reported, and no 10b5-1 trading plan was indicated in the filing.
Positive
- None.
Negative
- Director insider sale: Lawrence Wexler disposed of 25,000 TPB shares at $75.94, trimming his direct holding by roughly 7.6%, a potential negative sentiment signal.
Insights
TL;DR: Director sells 25k TPB shares (~7.6% stake cut); modestly negative signal, low fundamental impact.
The filing shows typical liquidity-driven selling rather than a wholesale exit: Wexler still owns 330k shares—worth roughly $25 million at the sale price—plus substantial options. While insider selling can pressure sentiment, the volume equals about 0.13 days of TPB’s average daily trading volume, limiting market impact. No derivative exercises accompanied the transaction, suggesting the sale was a straight reduction rather than profit-taking after option exercise. Investors should watch for additional sales that might signal broader insider bearishness, but a single 25k-share sale is not materially detrimental to TPB’s fundamentals.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 25,000 | $75.94 | $1.90M |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
Footnotes (1)
- The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021. Granted pursuant to the issuer's 2015 Equity Incentive Plan. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.68 to $76.38. The total reported in Column 5 includes 3,352 restricted stock units and 326,834 shares of common stock
